Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

225 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.
van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. van der Heijde D, et al. Among authors: bellamy n. J Rheumatol. 1997 Nov;24(11):2225-9. J Rheumatol. 1997. PMID: 9375888
A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
Bellamy N, Bensen WG, Beaulieu A, Siminovitch KA, Kraag GR, Lussier A, Ahmad S, Khanna VN, Davis P, Bell MJ, et al. Bellamy N, et al. J Rheumatol. 1995 May;22(5):915-20. J Rheumatol. 1995. PMID: 8587082 Clinical Trial.
RESULTS: In all, 382 patients [nabumetone (n = 192), diclofenac SR (n = 190)] participated in the trial. Improvement in all efficacy variables was noted, but there was no statistically significant difference between drugs. ...
RESULTS: In all, 382 patients [nabumetone (n = 192), diclofenac SR (n = 190)] participated in the trial. Improvement in all ef …
Variability of skin scores and clinical measurements in scleroderma.
Pope JE, Baron M, Bellamy N, Campbell J, Carette S, Chalmers I, Dales P, Hanly J, Kaminska EA, Lee P, et al. Pope JE, et al. Among authors: bellamy n. J Rheumatol. 1995 Jul;22(7):1271-6. J Rheumatol. 1995. PMID: 7562757 Clinical Trial.
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Bellamy N, et al. J Rheumatol. 1988 Dec;15(12):1833-40. J Rheumatol. 1988. PMID: 3068365 Clinical Trial.
Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.
Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Dec;18(12):1901-7. J Rheumatol. 1991. PMID: 1822109
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Dec;18(12):1908-15. J Rheumatol. 1991. PMID: 1795330
Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Dec;18(12):1893-900. J Rheumatol. 1991. PMID: 1795329
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Nov;18(11):1716-22. J Rheumatol. 1991. PMID: 1787494
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Nov;18(11):1709-15. J Rheumatol. 1991. PMID: 1787493
A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia.
Bellamy N, Muirden KD, Brooks PM, Barraclough D, Tellus MM, Campbell J. Bellamy N, et al. J Rheumatol. 1999 Jul;26(7):1593-9. J Rheumatol. 1999. PMID: 10405950
225 results
Jump to page
Feedback